genetic testing | pharmaphorum

Thursday 25 April 2024

Channels

Content type

Categories

Categories

Sort by

Order

genetic testing

News

T-cells attacking cancer cell illustration of microscopic photos

Genetic test can predict efficacy of chemotherapy in breast ...

Researchers have found that a genetic test can successfully predict whether chemotherapy would be beneficial for patients with the most common type of breast cancer – oestrogen-receptor pos

News

23andme

FDA approves consumer colorectal cancer test

The FDA will allow consumer DNA testing company 23andMe to give customers reports on their risk of hereditary colorectal cancer.

R&D

GSK signs $300m R&D deal with 23andMe

GSK signs $300m R&D deal with 23andMe

GlaxoSmithKline signed a $300 million research and development deal with mail gene profiling company 23andMe, gaining access to four million customers DNA information.

News

Science-DNA-technology

Direct-to-consumer DNA and microbiome test launched in Europ...

A UK-based company offering DNA and microbiome tests directly to consumers has expanded its services to 10 more European countries.

News

23andme

FDA to streamline access to consumer genetic tests

New regulations require less pre-market data for approval.

News

CRISPR-AZ

Fulcrum Therapeutics promises new drugs for rare disorders

Company launched following $55 million series A funding round.